ALGS
Aligos Therapeutics Inc. (ALGS)
NASDAQ · Healthcare
Aligos Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Aligos Therapeutics Inc. revenue for the quarter ending March 31, 2026 was 2.8 M, a 809.97% increase year-over-year.
- Aligos Therapeutics Inc. revenue for the twelve months ending March 31, 2026 was 4.8 M, a 18.51% increase year-over-year.
- Aligos Therapeutics Inc. annual revenue for 2025 was 2.2 M, a 39.46% decrease from 2024.
- Aligos Therapeutics Inc. annual revenue for 2024 was 3.6 M, a 41.67% decrease from 2023.
- Aligos Therapeutics Inc. annual revenue for 2023 was 6.2 M.
- Aligos Therapeutics Inc. annual revenue for 2022 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Aligos Therapeutics Inc. Earnings — FAQ
Aligos Therapeutics Inc. (ALGS) earnings over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALGS's earnings history?
The chart and table above show Aligos Therapeutics Inc.'s earnings by year and by quarter, including the growth rate.